Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Psychopharmacology
|
March 1, 1997
Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment
A Broocks, N C Briggs, T A Pigott, et al.
Chemical Research in Toxicology
|
July 1, 1988
Characterization of 7,12-dimethylbenz[a]anthracene-adenine nucleoside adducts
S C Cheng, A S Prakash, M A Pigott, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1986
Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons
D M Jerina, J M Sayer, S K Agarwal, et al.
Head & Neck
|
June 1, 2026
Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review
N D O'Donnell, E C Ward, L R Wishart, et al.
Journal of Clinical Psychopharmacology
|
January 2, 2013
Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial
Todd M Durell, Lenard A Adler, Dave W Williams, et al.
The Journal of Clinical Psychiatry
|
April 7, 1999
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder
M L Crismon, M Trivedi, T A Pigott, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Psychopharmacology
|
March 1, 1997
Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment
A Broocks, N C Briggs, T A Pigott, et al.
Chemical Research in Toxicology
|
July 1, 1988
Characterization of 7,12-dimethylbenz[a]anthracene-adenine nucleoside adducts
S C Cheng, A S Prakash, M A Pigott, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1986
Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons
D M Jerina, J M Sayer, S K Agarwal, et al.
Head & Neck
|
June 1, 2026
Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review
N D O'Donnell, E C Ward, L R Wishart, et al.
Journal of Clinical Psychopharmacology
|
January 2, 2013
Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial
Todd M Durell, Lenard A Adler, Dave W Williams, et al.
The Journal of Clinical Psychiatry
|
April 7, 1999
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder
M L Crismon, M Trivedi, T A Pigott, et al.
Page
of 8